People's United Financial’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$289K Sell
2,256
-636
-22% -$69.6K 0.01% 543
2021
Q4
$388K Sell
2,892
-1,776
-38% -$255K 0.01% 520
2021
Q3
$638K Buy
4,668
+28
+0.6% +$3.53K 0.01% 468
2021
Q2
$495K Sell
4,640
-768
-14% -$73.8K 0.01% 514
2021
Q1
$486K Sell
5,408
-136
-2% -$12.8K 0.01% 498
2020
Q4
$512K Sell
5,544
-560
-9% -$50K 0.01% 461
2020
Q3
$629K Sell
6,104
-408
-6% -$42.6K 0.02% 385
2020
Q2
$660K Buy
6,512
+2,420
+59% +$216K 0.02% 365
2020
Q1
$275K Buy
+4,092
New +$255K 0.01% 496

Other funds holding DXCM

People's United Financial's DXCM Position: Q1 2022 in Review

People's United Financial reduced its DexCom (DXCM) stake by 22% in Q1 2022, selling an estimated $69.6K and leaving 2,256 shares worth $289K. The position accounts for 0.01% of the portfolio, ranked #543.

People's United Financial first reported a position in DXCM in Q1 2020 and has held it in 9 quarters since. The position peaked at $660K in Q2 2020. 862 funds tracked by Wall St. Rank hold DXCM as of Q1 2022.

  • People's United Financial held 2,256 shares of DexCom worth $289K as of Q1 2022.
  • People's United Financial sold 636 DexCom shares in Q1 2022, an estimated $69.6K.
  • DexCom made up 0.01% of People's United Financial's portfolio in Q1 2022, its #543 holding.
  • People's United Financial first reported a position in DexCom in Q1 2020 and has held it in 9 quarters since.
  • People's United Financial's DexCom position peaked at $660K in Q2 2020.
  • 862 funds tracked by Wall St. Rank held DexCom as of Q1 2022.

Based on People's United Financial's 13F filing for Q1 2022, filed 10 May 2022.